Skip to content
Screener

Innoviva, Inc. INVA Common Stock

Common Stock at other companies

Merck & Co. logo
Merck & Co.MRK
6.5B0.0%
AbbVie logo
AbbVieABBV
$18M0.0%
Insmed logo
InsmedINSM
$2.18M+3.4%
Savara logo
SavaraSVRA
$204K+17.9%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$5K+25.0%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$1K0.0%

Other financials

Income statement

See full
Revenue$119.6M+19.3%
Gross profit$90.6M+9.0%
Operating income$50.9M+4.3%
Net income-$83.4M-231%
EPS (diluted)-$1.14-248%

Balance sheet

See full
Cash & equivalents$570.4M+43.5%
Total debt$269.7M-40.2%
Total equity$1.2B
Total assets$1.7B+27.7%

Cash flow

See full
Operating cash flow$52.0M+17.9%
CapEx$429.0K
Free cash flow$51.5M+16.9%

Valuation

See full
Market cap$1.49B+20.6%
Enterprise value$1.19B-7.6%
P/E4.2×-27.8×
P/S3.4×+0.1×

Profitability

See full
Gross margin72.2%-10.9pp
Operating margin36.9%-10.7pp
Net margin81.2%+70.8pp
FCF margin43.1%-11.1pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio16×+13.4×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Innoviva, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:26 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335235
Line itemJune 30, 2026 / (Unaudited)December 31, 2025 / *
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding
Common stock: $0.01 par value, 200,000 shares authorized, 72,637 and 74,636 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively727747
Additional paid-in capital859,992902,726
Retained earnings372,543269,368
Total stockholders’ equity1,233,2621,172,841
Total liabilities and stockholders’ equity$1,702,727$1,635,165

Item 1. Financial Statements

FAQ

What is Innoviva, Inc.'s common stock?
Innoviva, Inc. (INVA) reported common stock of $727K in Q2 2026.
How has Innoviva, Inc.'s common stock changed year-over-year?
Innoviva, Inc.'s common stock increased by 15.4% year-over-year, from $630K to $727K.
What is the long-term trend for Innoviva, Inc.'s common stock?
Over 5 years (2020 to 2025), Innoviva, Inc.'s common stock has grown at a -5.9% compound annual growth rate (CAGR), from $1.01M to $747K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Innoviva, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude